PYXS
PYXS
NASDAQ · Biotechnology

Pyxis Oncology Inc

$2.90
+0.04 (+1.40%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 14 88%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target +1,461.7% upside
Low Target $33.37
Average Target $45.29
High Target $67.77
Current Price $2.90
Current
$2.90
Target
$45.29
$33.37 $45.29 avg $67.77
Scenario Analysis
Bear Case
$33.37
1,050.7%
Low target
Base Case
$45.29
+1,461.7%
Avg target
Bull Case
$67.77
+2,236.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$5.55
-47.7% from high
52-Week Low
$1.03
+181.6% from low
Target vs 52W High
$45.29
+716.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%